You are here:
Glucoraphanin Enriched Broccoli
Beneforté has been naturally bred to contain 2-3 times more glucoraphanin, which research suggests could help to maintain cardiovascular health and to reduce the risk of cancer. PBL has secured the intellectual property rights in this innovation, on behalf of the John Innes Centre and the Institute and Food Research, and has managed its development and commercialisation since 1996.
Research on sulforaphane at the Norwich Research Park led by Professor Richard Mithen has been undertaken at both the John Innes Centre and Institute of Food Research, which are strategically funded by the Biotechnology and Biological Sciences Research Council. From identifying a high-glucoraphanin broccoli relative in the 1980s, it has taken many years of plant breeding, field trials and studies into potential health benefits, which led to the launch of Beneforté broccoli to your supermarket shelves in 2011.
||Please click here for the Beneforté Super Broccoli website, with information about how Beneforté was developed, recipe ideas from leading chefs and details of where to buy Beneforté.
News Articles and Press Releases
Oct 2015 - Beneforté Broccoli features on BBC Countryfile (25 October)
Apr 2015 - High glucoraphanin broccoli reduces cholesterol: new research studies published on Beneforté broccoli
Mar 2015 - PBL’s patent on glucoraphanin-rich broccoli : Valid
Jan 2014 - Increasing availability of the "Green Wonder" - Beneforté Broccoli
Dec 2013 - Beneforté recognised in top European technology transfer Impact showcase
Sep 2013 - Beneforté Super Broccoli Website goes live!
Aug 2013 - Eating Broccoli retunes Metabolism: Major breakthrough in understanding effects of Glucoraphanin
Apr 2013 - Beneforté Broccoli - New Research Published - Explained: Why Beneforte reliably delivers more glucoraphanin than standard broccoli
Sep 2012 - Funding Boost for Beneforté Broccoli
Nov 2011 - BBSRC Case Study: The Story Behind "Super Broccoli"
Oct 2011 - Beneforté Reaches Market in UK
Oct 2010 - Beneforté™: Broccoli from JIC and IFR Research is Presented to US Fresh Produce Market
Jan 2006 - New research published on cancer-fighting broccoli
Jan 2003 - Worldwide License to Cancer-Fighting Broccoli Granted to Seminis
Jan 2002 - Broccoli Patent Granted
Links and References
John Innes Centre
Institute of Food Research
Biotechnology and Biological Sciences Research Council
A diet rich in high glucoraphanin broccoli interacts with genotype to reduce discordance in plasma metabolite profiles through modulating mitochondrial disfunction
Am J Clin Nutr, September 2013; 98 (3): 712-722. Charlotte N Armah et al.
Genetic regulation of glucoraphanin accumulation in Beneforté® broccoli
New Phytologist, June 2013; 198 (4): 1085–1095. Maria H Traka et al.
New research will help make foods healthier, safer and more nutritious
Technology Strategy Board, Oct 2011.
Physiological effects of broccoli consumption
Phytochemistry Reviews, January 2009; 8 (1): 283-298. Elizabeth H Jeffery and Marcela Araya.
Glucosinolates, isothiocyanates and human health
Phytochemistry Reviews, January 2009; 8 (1): 269-282. Maria Traka and Richard Mithen.
Broccoli Consumption Interacts with GSTM1 to Perturb Oncogenic Signalling Pathways in the Prostate
PLoS One, July 2008; DOI: 10.1371/journal.pone.0002568. Maria Traka et al.
Prospective Study of Fruit and Vegetable Intake and Risk of Prostate Cancer
JNCI J Natl Cancer Inst, July 2007; 99 (15): 1200-1209. Victoria A Kirsh et al.
Molecular basis for chemoprevention by sulforaphane: a comprehensive review
Cellular and Molecular Life Sciences, May 2007; 64 (9): 1105-1127. N Juge, R F Mithen and M Traka.
Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli
Am J Clin Nutr, December 2005; 82 (6): 1283-1291. Amy V Gasper et al.
Dietary glucosinolates as blocking agents against carcinogenesis: glucosinolate breakdown products assessed by induction of quinone reductase activity in murine hepa1c1c7 cells
Carcinogenesis, May 1995; 16 (5): 1191-1194. Najlaá Tawfiq et al.